PR Newswire
17 Apr 2023, 09 GMT+10
![]() |
BANGALORE, India and DELAWARE CITY, Del. and ADELAIDE, Australia, April 17, 2023 /PRNewswire/ -- Bugworks Research Inc., a clinical-stage biopharmaceutical company, is set to present its latest research findings on the novel bacterial topoisomerase inhibitor, BWC0977 at the upcoming 33rd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Copenhagen, Denmark.
The eight posters highlight data from the microbiological and efficacy studies of the clinical candidate, BWC0977 that exhibits broad-spectrum activity against a globally, diverse panel of Gram-positive, Gram-negative and biothreat pathogens. Additionally, data from a range of studies, including in vitro biochemical assays, in vitro resistance frequency studies, minimum inhibitory concentration (MIC90) data against multi-drug resistant clinical isolates from around the world, and in vivo efficacy data in mice and rat models of infection will be presented.
These studies were conducted in collaboration with scientists at the Walter Reed Army Institute of Research (WRAIR), Bethesda, USA, University of Liverpool, United Kingdom, University of Texas Medical Branch, USA, International Health Management Associates (IHMA), USA and TheraIndx Lifesciences Pvt. Ltd., India.
"ECCMID 2023 is a globally renowned platform in Infectious Diseases R&D arena, and we are proud to have the opportunity to showcase the pre-clinical highlights of our drug candidate BWC0977; a first-of-its-kind in over six decades that has the potential to treat an entire gamut of infections caused by hard-to-treat Gram-negative and Gram-positive bacterial pathogens," says Dr. Vasanthi Ramachandran, Vice President - Collaborations, Bugworks Research India.
Bugworks Research is at the forefront of developing novel antibiotics to combat the growing threat of antimicrobial resistance. The company's cutting-edge research is focused on discovering and developing small molecule drugs that target bacterial enzymes essential for their survival.
The ECCMID conference is a leading global forum for infectious diseases and clinical microbiology. Bugworks Research's presentations will take place on April 13th, 2023, during the poster session. Attendees are invited to visit the Bugworks Research booth to learn more about the company's innovative approach to fighting antibiotic resistance.
About Bugworks
Bugworks Research Inc, (Bugworks), is a clinical stage biopharmaceutical company, that is developing novel multi target therapeutic assets in the anti-infectives and immuno-oncology (IO) areas by integrating the latest innovations in computational biology, pharmacology, structural-biology, and medicinal chemistry. BWC0977 is currently in a Phase 1 clinical trial and is targeted to address unmet needs of serious hospital & community infections, and bacterial biothreats. Its asset for IO is in the late pre-clinical stage, targets multiple cancers and is expected to be used either as standalone or in combination with immune checkpoint therapies.
For further information, please visit www.bugworksresearch.com
Media Contact Information
Concept Public Relations
Archana Jain ([email protected] / +91 98455 41244)
Aditi Nair ([email protected] / +91 9071949810)
Get a daily dose of Philippine Times news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Philippine Times.
More InformationFREMONT, California: Brain implant company Neuralink announced that it has received approval from US regulators to begin human brain implant ...
JEFFERSONVILLE, Indiana: Randy Lankford, owner of Lankford Funeral Home and Family Center in Jeffersonville, Indiana, has pleaded guilty to more ...
DENVER, COLORADO: A federal judge has ruled that a rural Colorado school district can ban a high school student from ...
ZURICH, Switzerland: In one of the largest legal awards ever against Credit Suisse, the bank was ordered to pay $926 ...
DETROIT, Michigan: Amid broader global concerns over semiconductor chip supplies, sanctions and national security, Chinese commerce minister Wang Wentao said ...
WASHINGTON D.C.: The White House announced this week that President Joe Biden has chosen US Air Force chief General Charles ...
LAS VEGAS, Nevada: A bill was introduced in the Nevada Legislature to provide the Oakland Athletics up to $380 million ...
WASHINGTON D.C.: Due to one of the tightest labor markets in decades, teenagers, who have been vital for filling summer ...
NEW YORK, New York - Republicans were in uproar Tuesday over the deal hammered out by President Joe Biden and ...
DETROIT, Michigan: After Ford Motor Co announced an agreement with Tesla to allow autos to be charged using the Tesla ...
WARSAW, Poland: Plans are underway in Poland to gradually raise the minimum wage twice in 2024. The wage plan has ...
BEIJING, China: China will put into commercial operation its first large passenger airliner, in a bid to challenge western plane ...